{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T19:54:35Z","timestamp":1779134075785,"version":"3.51.4"},"reference-count":46,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"Medical University of Silesia","doi-asserted-by":"publisher","award":["BNW-1-014\/N\/5\/I"],"award-info":[{"award-number":["BNW-1-014\/N\/5\/I"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Inflammatory bowel diseases (IBD), encompassing ulcerative colitis (UC) and Crohn\u2019s disease (CD), are characterized by a complex interplay between chronic inflammatory process and extracellular matrix (ECM) remodeling. This pilot study aims to evaluate the serum levels of three ECM-related proteins\u2014periostin, galectin-3, and tenascin C\u2014as biomarkers supporting IBD diagnosis. Serum concentration of periostin, galectin-3 and tenascin C were measured using the ELISA method in 49 patients with IBD and 30 healthy individuals. Periostin and galectin-3 levels differed significantly between IBD patients and healthy individuals, whereas tenascin C levels did not show a significant difference. The ROC curve analysis identified periostin as the most promising biomarker for differentiation of both UC and CD from healthy individuals. In UC patients, periostin distinguished them from healthy individuals with excellent accuracy (AUC = 0.922), high sensitivity (100%), and good specificity (77.8%). Similarly, in CD patients, periostin demonstrated excellent diagnostic performance with AUC of 0.943, high sensitivity (100%) and good specificity (77.8%). Galectin-3 also showed potential as a diagnostic marker, which discriminated both UC and CD patients with high accuracy of AUC = 0.745 in UC and AUC = 0.691 in CD groups. Moreover, serum galectin-3 levels correlated with CRP levels (r = 0.603, p &lt; 0.05) in the CD group. After one year of conventional anti-inflammatory treatment in CD patients, levels of periostin (p &lt; 0.001) and galectin-3 (p &lt; 0.05) significantly decreased. In contrast UC patients, receiving anti-TNF-\u03b1 biological therapy showed a significant increase in galectin-3 (p &lt; 0.05) concentrations. Obtained results indicate that circulating periostin and galectin-3 emerge as promising biomarkers for differentiating both UC and CD patients from healthy individuals. Given the significant correlation between galectin-3 and CRP serum levels, galectin-3 may also serve as a useful marker for monitoring disease activity in CD. Furthermore, galectin-3 may be helpful in monitoring the response to both biological or conventional anti-inflammatory treatment in UC and CD patients. Periostin, in turn, may be particularly valuable for evaluating efficacy of conventional anti-inflammatory therapy in CD.<\/jats:p>","DOI":"10.3390\/ijms262110439","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T09:16:07Z","timestamp":1761642967000},"page":"10439","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic Potential of Periostin, Galectin-3 and Tenascin C Serum Measurements in Inflammatory Bowel Disease: Pilot Study"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9818-9221","authenticated-orcid":false,"given":"Aleksandra","family":"G\u00f3recka","sequence":"first","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6393-0668","authenticated-orcid":false,"given":"Agnieszka","family":"Jura-P\u00f3\u0142torak","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8445-2490","authenticated-orcid":false,"given":"Anna","family":"Szeremeta","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2307-5884","authenticated-orcid":false,"given":"Katarzyna","family":"Komosinska-Vassev","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","article-title":"Mechanisms of Disease: Inflammatory Bowel Diseases","volume":"94","author":"Ramos","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.suc.2019.08.001","article-title":"Inflammatory Bowel Disease Presentation and Diagnosis","volume":"99","author":"Flynn","year":"2019","journal-title":"Surg. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cgh.2019.07.005","article-title":"Ulcerative Colitis and Crohn\u2019s Disease Have Similar Burden and Goals for Treatment","volume":"18","author":"Ananthakrishnan","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/his.12263","article-title":"Ulcerative colitis or Crohn\u2019s disease? Pitfalls and problems","volume":"64","author":"Feakins","year":"2014","journal-title":"Histopathology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cca.2020.08.025","article-title":"Calprotectin in inflammatory bowel disease","volume":"510","author":"Qujeq","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_6","first-page":"155","article-title":"Biomarkers in inflammatory bowel diseases: Insight into diagnosis, prognosis and treatment","volume":"10","author":"Norouzinia","year":"2017","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/17474124.2019.1673729","article-title":"The intestinal tissue homeostasis\u2014The role of extracellular matrix remodeling in inflammatory bowel disease","volume":"13","author":"Mortensen","year":"2019","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yang, L., Guo, T., Chen, Y., and Bian, K. (2022). The Multiple Roles of Periostin in Non-Neoplastic Disease. Cells, 12.","DOI":"10.3390\/cells12010050"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1242\/jcs.190546","article-title":"Tenascin-C at a glance","volume":"129","author":"Midwood","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_10","first-page":"599","article-title":"Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy","volume":"41","author":"Dong","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"105881","DOI":"10.1016\/j.biocel.2020.105881","article-title":"The therapeutic potential of galectin-3 inhibition in fibrotic disease","volume":"130","author":"Slack","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00018-013-1494-y","article-title":"The role of periostin in tissue remodeling across health and disease","volume":"71","author":"Conway","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1007\/s00018-017-2644-4","article-title":"Periostin and its interacting proteins in the construction of extracellular architectures","volume":"74","author":"Kii","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"C1065","DOI":"10.1152\/ajpcell.00035.2020","article-title":"Wound healing and fibrosis: A contrasting role for periostin in skin and the oral mucosa","volume":"318","author":"Nikoloudaki","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Koh, S.J., Choi, Y., Kim, B.G., Lee, K.L., Kim, D.W., Kim, J.H., Kim, J.W., and Kim, J.S. (2016). Matricellular Protein Periostin Mediates Intestinal Inflammation through the Activation of Nuclear Factor \u03baB Signaling. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149652"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wang, Y., Wang, G., and Liu, H. (2022). Tenascin-C: A Key Regulator in Angiogenesis during Wound Healing. Biomolecules, 12.","DOI":"10.3390\/biom12111689"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"11703","DOI":"10.1038\/ncomms11703","article-title":"Tenascin-C drives persistence of organ fibrosis","volume":"7","author":"Bhattacharyya","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4161\/19336918.2014.987587","article-title":"Tenascin-C: Form versus function","volume":"9","author":"Giblin","year":"2015","journal-title":"Cell Adh. Migr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12079-018-0453-7","article-title":"Galectin-3 regulation of wound healing and fibrotic processes: Insights for chronic skin wound therapeutics","volume":"12","author":"McLeod","year":"2018","journal-title":"J. Cell Commun. Signal."},{"key":"ref_20","first-page":"9247574","article-title":"The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens","volume":"2017","author":"Ortega","year":"2017","journal-title":"Mediators Inflamm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/ecco-jcc\/jjw013","article-title":"Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1\u03b2 in Macrophages","volume":"10","author":"Nikolic","year":"2016","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/gutjnl-2016-313535","article-title":"CD177+ neutrophils as functionally activated neutrophils negatively regulate IBD","volume":"67","author":"Zhou","year":"2018","journal-title":"Gut"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gut.2005.081646","article-title":"Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factor","volume":"56","author":"Lippert","year":"2007","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00441-016-2426-6","article-title":"Periostin as a multifunctional modulator of the wound healing response","volume":"365","author":"Walker","year":"2016","journal-title":"Cell Tissue Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Coelho, T., Sonnenberg-Riethmacher, E., Gao, Y., Mossotto, E., Khojanazarov, A., Griffin, A., Mukanova, S., Ashimkhanova, A., Haggarty, R., and Borissenko, A. (2021). Expression profile of the matricellular protein periostin in paediatric inflammatory bowel disease. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-85096-7"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Nishiyama, T., Kii, I., Kashima, T.G., Kikuchi, Y., Ohazama, A., Shimazaki, M., Fukayama, M., and Kudo, A. (2011). Delayed re-epithelialization in periostin-deficient mice during cutaneous wound healing. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018410"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/ibd\/izaf009","article-title":"Serum Periostin is Able to Stratify Type 2-Dominant Ulcerative Colitis","volume":"31","author":"Takedomi","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yu, T.B., Dodd, S., Yu, L.G., and Subramanian, S. (2020). Serum galectins as potential biomarkers of inflammatory bowel diseases. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0227306"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00011-009-0016-8","article-title":"Detection of galectin-3 in patients with inflammatory bowel diseases: New serum marker of active forms of IBD?","volume":"58","author":"Smetana","year":"2009","journal-title":"Inflamm. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_31","first-page":"129","article-title":"Galectin-3: A novel biomarker for the prognosis of heart failure","volume":"90","author":"Amin","year":"2017","journal-title":"Clujul Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Hara, A., Niwa, M., Noguchi, K., Kanayama, T., Niwa, A., Matsuo, M., Hatano, Y., and Tomita, H. (2020). Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases. Biomolecules, 10.","DOI":"10.3390\/biom10030389"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1475705","DOI":"10.1155\/2019\/1475705","article-title":"Tenascin-C Is Increased in Inflammatory Bowel Disease and Is Associated with response to Infliximab Therapy","volume":"2019","author":"Ning","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cellimm.2015.01.017","article-title":"Downregulating galectin-3 inhibits proinflammatory cytokine production by human monocyte-derived dendritic cells via RNA interference","volume":"294","author":"Chen","year":"2015","journal-title":"Cell. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"European Crohn\u2019s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000527846","article-title":"Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease","volume":"104","author":"Sakurai","year":"2023","journal-title":"Digestion"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jcag\/gwaa009","article-title":"Fecal Calprotectin, CRP and Leucocytes in IBD Patients: Comparison of Biomarkers With Biopsy Results","volume":"4","author":"Kyle","year":"2020","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"ref_38","first-page":"620","article-title":"C-reactive protein as a marker for inflammatory bowel disease","volume":"53","author":"Vermeire","year":"2004","journal-title":"Gut"},{"key":"ref_39","first-page":"78","article-title":"IBSEN Study Group. C-reactive protein: A predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study","volume":"103","author":"Henriksen","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/08923973.2023.2229510","article-title":"TNF-\u03b1 promotes CXCL-1\/8 production in keratinocytes by downregulating galectin-3 through NF-\u03baB and hsa-miR-27a-3p pathway to contribute psoriasis development","volume":"45","author":"Qiu","year":"2023","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s11626-012-9540-x","article-title":"Galectin-3 expression in response to LPS, immunomodulatory drugs and exogenously added galectin-3 in monocyte-like THP-1 cells","volume":"48","author":"Dabelic","year":"2012","journal-title":"In Vitr. Cell. Dev. Biol. Anim."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2006.02.046","article-title":"Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals","volume":"118","author":"Takayama","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Luchak, A., Solomon, L.A., Kanagalingam, T., Vijeyakumaran, M., Rowe, B.H., and Cameron, L. (2020). Comparative efficacy of glucocorticoid receptor agonists on Th2 cell function and attenuation by progesterone. BMC Immunol., 21.","DOI":"10.1186\/s12865-020-00383-8"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0167-0115(97)01063-X","article-title":"Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures","volume":"73","author":"Franchimont","year":"1998","journal-title":"Regul. Pept."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/ard.61.8.723","article-title":"Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13","volume":"61","author":"Pittoni","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ecco-jcc\/jju008","article-title":"Response to infliximab therapy in ulcerative colitis is associated with decreased monocyte activation, reduced CCL2 expression and downregulation of Tenascin C","volume":"9","author":"Magnusson","year":"2015","journal-title":"J. Crohn\u2019s Colitis"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10439\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T09:32:00Z","timestamp":1761643920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":46,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262110439"],"URL":"https:\/\/doi.org\/10.3390\/ijms262110439","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]}}}